a poor prognosis, since distant metastases are present in the majority of patients at the time of diagnosis. Because of the rarity of cardiac angiosarcoma, there are no standard applicable guidelines for treatment. Surgery, adjuvant chemotherapy, and radiation have been used. Despite aggressive treatment, the prognosis is poor, and death usually occurs within one year after the diagnosis. Early heart transplantation has been proposed but may not be possible because of the frequent presence of metastases at the time of the diagnosis.
Case Summary -1:
A 33-year-old previous healthy male presented to a local hospital with complaints of dyspnea of HRCT chest showed features suggestive of a large mixed dense lesion in the anterior mediastinum causing mediastinal shift to left. The lesion measuring 10.1 x 10.4 x 8.9 cm showed multiple hyperdense foci within suggestive of haemorrhage. Tumour was found to involve the adjacent pericardium, encasing aorta, pulmonary artery and SVC. Superiorly it was extending into manubriosternum joint and inferiorly upto the diaphragm. Multiple hypodense lesions in the liver were detected suggestive of ?cardiac sarcoma with liver metastasis. Bone scan showed increased tracer uptake in right ilium, focal uptake in right frontal skull, manubrium, D11 vertebra and left 3rd rib anteriorly. The patient was treated with 6 cycles of Inj Paclitaxel 175mg/m2 q3 weekly for 6 cycles. Post chemotherapy evaluation with CECT chest and abdomen showed lobulated heterogeneous enhancing mass lesion arising from right atrium extending into the anterior mediastinum. Multiple liver and bone metastasis detected. Bone scan showed new bony lesions compared to the previous scan suggestive of Progressive disease. The patient is currently on second line chemotherapy with Inj. Liposomal Doxorubicin 50 mg/m2 q 3weekly.
